| # | Drug | Count |
|---|---|---|
| 0 | SUNITINIB MALATE | 196 |
| 1 | PAZOPANIB HYDROCHLORIDE | 90 |
| 2 | CABOZANTINIB | 57 |
| 3 | AXITINIB | 46 |
| 4 | OMEPRAZOLE MAGNESIUM | 40 |
| 5 | ASPIRIN | 38 |
| 6 | ASPIRIN 325 MG | 37 |
| 7 | ASPIRIN 81 MG | 37 |
| 8 | EVEROLIMUS | 35 |
| 9 | NIVOLUMAB | 31 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SUNITINIB MALATE | 196 | 0.0050 |
| 1 | PAZOPANIB HYDROCHLORIDE | 90 | 0.0033 |
| 2 | TEMSIROLIMUS | 15 | 0.0033 |
| 3 | AXITINIB | 46 | 0.0024 |
| 4 | CABOZANTINIB | 57 | 0.0012 |
| 5 | ERGOCALCIFEROL | 30 | 0.0010 |
| 6 | SORAFENIB | 16 | 0.0008 |
| 7 | EVEROLIMUS | 35 | 0.0007 |
| 8 | NIVOLUMAB | 31 | 0.0003 |
| 9 | DOCUSATE SODIUM | 11 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-Glucosidase Inhibitor [EPC] | 5 | 0.0010 |
| 1 | Provitamin D2 Compound [EPC] | 30 | 0.0010 |
| 2 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 37 | 0.0004 |
| 5 | Bismuth [EPC] | 2 | 0.0004 |
| 6 | Oxytocic [EPC] | 1 | 0.0003 |
| 7 | Calcitonin [EPC] | 1 | 0.0003 |
| 8 | Radioactive Diagnostic Agent [EPC] | 1 | 0.0003 |
| 9 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |